Evidence map›Paper›PMID 36514358›Full record

ArticleJournal of inflammation research2022

DNA Repair Mechanisms are Activated in Circulating Lymphocytes of Hospitalized Covid-19 Patients.

Maria Belland Olsen, Camilla Huse, Mirta Mittelstedt Leal de Sousa, Sarah Louise Murphy, Antonio Sarno, Tobias Sebastian Obermann, Kuan Yang, Jan Cato Holter, Marte Jøntvedt Jørgensen, Erik Egeland Christensen and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. SARS-CoV-2 and the DNA damage response.The Journal of general virology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Maria Belland OlsenResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-0136-4290
Camilla HuseResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Mirta Mittelstedt Leal de SousaDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Sarah Louise MurphyResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-3086-8647
Antonio SarnoDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Tobias Sebastian ObermannDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Kuan YangResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-2246-4864
Jan Cato HolterInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0003-1618-5022
Marte Jøntvedt JørgensenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Erik Egeland ChristensenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Wei WangDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Ping JiDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Lars HeggelundDepartment of Internal Medicine, Vestre Viken Hospital Trust, Drammen, Norway.ORCID 0000-0002-1669-1032
Hedda HoelResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Anne Margarita Dyrhol-RiiseInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ida GregersenResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Pål AukrustResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Magnar BjøråsDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Bente HalvorsenResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-6529-6485
Tuva Børresdatter DahlDivision of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NONorwegian University of Science and Technology · NOSINTEF · NOVestre Viken Hospital Trust · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Reactive oxygen species (ROS) are an important part of the inflammatory response during infection but can also promote DNA damage. Due to the sustained inflammation in severe Covid-19, we hypothesized that hospitalized Covid-19 patients would be characterized by increased levels of oxidative DNA damage and dysregulation of the DNA repair machinery. Patients and Methods: Levels of the oxidative DNA lesion 8-oxoG and levels of base excision repair (BER) proteins were measured in peripheral blood mononuclear cells (PBMC) from patients (8-oxoG, n = 22; BER, n = 17) and healthy controls (n = 10) (Cohort 1). Gene expression related to DNA repair was investigated in two independent cohorts of hospitalized Covid-19 patients (Cohort 1; 15 patents and 5 controls, Cohort 2; 15 patients and 6 controls), and by publicly available datasets. Results: Patients and healthy controls showed comparable amounts of oxidative DNA damage as assessed by 8-oxoG while levels of several BER proteins were increased in Covid-19 patients, indicating enhanced DNA repair in acute Covid-19 disease. Furthermore, gene expression analysis demonstrated regulation of genes involved in BER and double strand break repair (DSBR) in PBMC of Covid-19 patients and expression level of several DSBR genes correlated with the degree of respiratory failure. Finally, by re-analyzing publicly available data, we found that the pathway Conclusion: Although beneficial by protecting against DNA damage, long-term activation of the DNA repair machinery could also contribute to persistent inflammation, potentially through mechanisms such as the induction of cellular senescence. However, further studies that also include measurements of additional markers of DNA damage are required to determine the role and precise molecular mechanisms for DNA repair in SARS-CoV-2 infection.

Indexed as

base excision repairCovid-19DNA damageDNA repairdouble strand break repairoxidative stress

Identifiers

PMID36514358
PMCPMC9741826
OpenAlexW4310837316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.